The LIT participates in the Leibniz Lab Pandemic Preparedness

How can we better prepare for future pandemics? This question is the focus of the Leibniz Lab Pandemic Preparedness, of which the Leibniz Institute for Immunotherapy (LIT) recently became a member. In a Leibniz Lab, a wide range of Leibniz Institutes collaborate on an interdisciplinary basis and with stakeholders from society, politics and business to develop practical solutions to major societal challenges. The LIT will contribute to this by investigating the molecular mechanisms of secondary diseases resulting from infections, such as ME/CFS or Long COVID syndrome, in greater detail.